Intelligence · Clinical Development
Pipeline search results
Programs matching “ibrutinib” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 10 pipeline programs matching "ibrutinib" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Ibrutinib
Janssen Cilag International NV
Chronic Lymphocytic Leukemia
1 trial -
Ibrutinib hard capsule for oral use, Ibrutinib
AbbVie Deutschland GmbH & Co. KG
Follicular Lymphoma
1 trial -
Remibrutinib
Novartis Pharmaceuticals
Chronic Inducible Urticaria
1 trial -
Remibrutinib
Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
1 trial -
IBRUTINIB
Fondazione Telethon ETS
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or CLL-like monoclonal B-cell lymphocytosis
1 trial -
Ibrutinib
Karyopharm Therapeutics Inc
Lymphoma
1 trial -
Ibrutinib
United Therapeutics Europe Ltd
Asymptomatic COVID-19 Infection Laboratory-Confirmed
1 trial -
Ibrutinib 560 mg
United Therapeutics Europe Ltd
Mantle Cell Lymphoma
1 trial -
R-EPOCH in Combination With Ibrutinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Richter Transformation
1 trial -
Ibrutinib
AbbVie Deutschland GmbH & Co. KG
1. Follicular Lymphoma 2. Chronic Lymphocytic Leukemia 3. Waldenstrom macroglobulinemia 4. Multiple Myeloma 5. Marginal Zone Lymphoma 6. Diffuse Large B-Cell Lymphoma 7. Urothelial Carcinoma 8. Breast Cancer 9. Acute Myeloid Leukemia 10. Graft vs Host Disease 11. Mantle Cell Lymphoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.